Skip to content

A Study of Wrist Actigraphy in Overweight and Obese Adults With Sleep Disorders

A Study of Wrist Actigraphy in Overweight and Obese Adults With Sleep Disorders

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02260297
Enrollment
69
Registered
2014-10-09
Start date
2014-01-31
Completion date
2014-10-31
Last updated
2014-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Disorders

Keywords

Actigraphy, overweight and obese adults, sleep disorders

Brief summary

70 overweight or obese adults with sleep disorders will be recruited for this study, in which the investigators aim to compare wrist actigraphy with polysomnography (PSG) for sleep monitoring. It is to evaluate the applications of Jawbone Up2 with the sleep parameters derived from this actigraphy.

Detailed description

As an observation study, it will recruit 70 overweight or obese patients with sleep disorders who meet the selection criteria: clinical records and AIS at a tertiary hospital. The patients will sign the informed consent form. The involved patients and doctors will receive related training. These patients will receive the sleep monitoring from 21:00 to 6:00 in sleep monitoring laboratory in Ruijin Hospital. They will receive the PSG and Jawbone Up 2 sleep monitoring at the same time. Sleep parameters derived from actigraphy and PSG will be compared in multiple night recordings such as total sleep time, wake after sleep onset, sleep onset latency, awakening, sleep efficiency, total time in bed,. The aim is to assess the validation of actigraphy in overweight or obese patients with sleep disorders.

Interventions

DEVICEWrist Actigraphy(motion sensors)with light sensors-Jawbone Up 2

Sponsors

Ruijin Hospital
CollaboratorOTHER
Shanghai Jiao Tong University School of Medicine
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years of age or older * Have one or more sleep disorders such as consecutive snoring, insomnia, sleep apnea, narcolepsy, delayed sleep phase syndrome * Athens Insomnia Scale (AIS)\>6 * BMI\>25 * Agree to participate in the study and have signed the inform consent form

Exclusion criteria

* Terminal illness * Physically-challenged and paralyzed patients * Intend to receive selective surgery, to get pregnancy and breast feeding in three months * Long-term use of the sleeping pills * Hearing loss or severe visual disorder; * Mental disorders * Dementia or communication disorders * Unable to complete an all night sleep monitoring

Design outcomes

Primary

MeasureTime frame
Total Sleep Time, TST10 hrs
Wake After Sleep Onset, WASO10 hrs

Secondary

MeasureTime frame
Sleep Onset Latency, SOL10 hrs
Frequency of arousal during sleep,awakenings10 hrs
Sleep Efficiency, SE10 hrs

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026